About Martin Heidecker
Form D filings for Adaptive Phage Therapeutics in 2023 list Martin Heidecker as director.
Martin Heidecker first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Martin Heidecker in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Martin Heidecker works with at each company, as listed on that company's latest Form D.
Adaptive Phage Therapeutics, Inc. · Form D, Jun 9, 2023
JL
Jonathan Leff
Director
JJ
Jana Jensen
Director
CM
Carl Merril
Director
IH
Ian Hardy
Director
MO
Michael Orndorff
Executive officer
GM
Gregory Merril
Chief Executive Officer and director
JG
Jesse Goodman
Director
RM
Raymond Martz
Director
EL
Evan Loh
Director
SB
Subhendu Basu
Executive officer